Voronoi, Inc. (310210.KQ) — Stock Score Summary

Voronoi, Inc. (310210.KQ) has a MoatMap StockRank of 13/100 based on Quality (26/100), Value (33/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL.

Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment...

Key Financial Metrics

Price$129.41
Market Cap$2.3B
P/E (Forward)-67.78
Price/Book34.07
Return on Equity-69.9%
Return on Invested Capital-29.4%
Debt/Equity38.78
Gross Margin100.0%
Operating Margin-824.0%
Free Cash Flow$-18K

Voronoi, Inc. operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Voronoi, Inc.’s (310210.KQ) StockRank?
MoatMap’s StockRank for Voronoi, Inc. (310210.KQ) is 13/100, with a Strong Sell signal. It is a composite of Quality (26), Value (33), and Momentum (37) factor ranks across MoatMap’s 19,000+ stock universe.
Does Voronoi, Inc. have an economic moat?
Voronoi, Inc. (310210.KQ) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Voronoi, Inc. a buy, hold, or sell?
MoatMap’s current signal for Voronoi, Inc. (310210.KQ) is Strong Sell, based on a StockRank of 13/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Voronoi, Inc. in?
Voronoi, Inc. (310210.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).